|7.33|| -0.16 / -2.14%|
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Lake Forest, CA.
|Jerrell W. Shelton||Chairman, President & Chief Executive Officer|
|Robert S. Stefanovich||Chief Financial Officer, Secretary & Treasurer|
|Bret Bollinger||Chief Technology Officer|
|Mark W. Sawicki||Chief Commercial Officer|
|Colin Coffua||Vice President-Strategic Accounts|